Moleculin Biotech

Moleculin Biotech is a company listed under the stock ticker MBRX (US).

View the org chart displaying its 11 main executives

Most searched biographies at Moleculin Biotech

• Walter Klemp, Chairman of the Board and Chief Executive Officer
• Elizabeth Cermak, Director
• Robert George, Director

Create your alert
to follow the executive moves at Moleculin Biotech.

Moleculin Biotech has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Moleculin Biotech

Social media about Moleculin Biotech

• Moleculin Biotech on Wikipedia, Google News & Yahoo Finance
• Moleculin Biotech on LinkedIn, Twitter & YouTube

Contact by email its executives including Walter Klemp

Call Moleculin Biotech at +1 877...

View the org chart

Register to receive your alert

Report an error